Nevertheless, further studies should be performed to gain more detailed information to clarify whether SKBR3, as a representative cell line of the HER2-positive breast cancer subtype, represents another independent metabophenotype or is just a special type within one of the already well-described metabophenotypes. Here, ERBB2 is linked to breast carcinoma.